{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:51:06Z","timestamp":1773273066737,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T00:00:00Z","timestamp":1458864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1038\/gt.2016.32","type":"journal-article","created":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T11:41:21Z","timestamp":1458906081000},"page":"592-596","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The relevance of coagulation factor X protection of adenoviruses in human sera"],"prefix":"10.1038","volume":"23","author":[{"given":"M R","family":"Duffy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Doszpoly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S A","family":"Nicklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A H","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,25]]},"reference":[{"key":"BFgt201632_CR1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.cell.2008.01.016","volume":"132","author":"SN Waddington","year":"2008","unstructured":"Waddington SN, McVey JH, Bhella D, Parker AL, Barker K, Atoda H et al. Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 2008; 132: 397\u2013409.","journal-title":"Cell"},{"key":"BFgt201632_CR2","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nm.3107","volume":"19","author":"Z Xu","year":"2013","unstructured":"Xu Z, Qiu Q, Tian J, Smith JS, Conenello GM, Morita T et al. Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement. Nat Med 2013; 19: 452\u2013457.","journal-title":"Nat Med"},{"key":"BFgt201632_CR3","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1182\/blood-2008-09-178459","volume":"113","author":"RC Carlisle","year":"2009","unstructured":"Carlisle RC, Di Y, Cerny AM, AF-P Sonnen, Sim RB, Green NK et al. Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1. Blood 2009; 113: 1909\u20131918.","journal-title":"Blood"},{"key":"BFgt201632_CR4","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.1073\/pnas.0711757105","volume":"105","author":"O Kalyuzhniy","year":"2008","unstructured":"Kalyuzhniy O, Di Paolo NC, Silvestry M, Hofherr SE, Barry MA, Stewart PL et al. Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc Natl Acad Sci USA 2008; 105: 5483\u20135488.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201632_CR5","doi-asserted-by":"publisher","first-page":"10914","DOI":"10.1128\/JVI.05382-11","volume":"85","author":"MR Duffy","year":"2011","unstructured":"Duffy MR, Bradshaw AC, Parker AL, McVey JH, Baker AH . A cluster of basic amino acids in the factor X serine protease mediates surface attachment of adenovirus\/FX complexes. J Virol 2011; 85: 10914\u201310919.","journal-title":"J Virol"},{"key":"BFgt201632_CR6","doi-asserted-by":"publisher","first-page":"e1001142","DOI":"10.1371\/journal.ppat.1001142","volume":"6","author":"AC Bradshaw","year":"2010","unstructured":"Bradshaw AC, Parker AL, Duffy MR, Coughlan L, van Rooijen N, K\u00e4h\u00e4ri V-M et al. Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X. PLoS Pathog 2010; 6: e1001142.","journal-title":"PLoS Pathog"},{"key":"BFgt201632_CR7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1128\/JVI.01939-15","volume":"90","author":"AK Zaiss","year":"2016","unstructured":"Zaiss AK, Foley EM, Lawrence R, Schneider LS, Hoveida H, Secrest P et al. Hepatocyte heparan sulfate is required for adeno-associated virus 2 but dispensable for adenovirus 5 liver transduction in vivo. J Virol 2016; 90: 412\u2013420.","journal-title":"J Virol"},{"key":"BFgt201632_CR8","doi-asserted-by":"publisher","first-page":"e1004673","DOI":"10.1371\/journal.ppat.1004673","volume":"11","author":"J Ma","year":"2015","unstructured":"Ma J, Duffy MR, Deng L, Dakin RS, Uil T, Custers J et al. Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo. PLoS Pathog 2015; 11: e1004673.","journal-title":"PLoS Pathog"},{"key":"BFgt201632_CR9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1126\/science.1226625","volume":"338","author":"K Doronin","year":"2012","unstructured":"Doronin K, Flatt JW, Di Paolo NC, Khare R, Kalyuzhniy O, Acchione M et al. Coagulation factor X activates innate immunity to human species C adenovirus. Science 2012; 338: 795\u2013798.","journal-title":"Science"},{"key":"BFgt201632_CR10","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1128\/JVI.03576-14","volume":"89","author":"K Eichholz","year":"2015","unstructured":"Eichholz K, Mennechet FJ, Kremer EJ . Human coagulation factor X-adenovirus type 5 complexes poorly stimulate an innate immune response in human mononuclear phagocytes. J Virol 2015; 89: 2884\u20132891.","journal-title":"J Virol"},{"key":"BFgt201632_CR11","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1182\/blood-2009-03-208835","volume":"114","author":"R Alba","year":"2009","unstructured":"Alba R, Bradshaw AC, Parker AL, Bhella D, Waddington SN, Nicklin SA et al. Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer. Blood 2009; 114: 965\u2013971.","journal-title":"Blood"},{"key":"BFgt201632_CR12","first-page":"1652","volume-title":"Encyclopedia of Nanotechnology","author":"M Wright","year":"2012","unstructured":"Wright M . Nanoparticle tracking analysis In: Bhushan B (ed). Encyclopedia of Nanotechnology. Springer: Netherlands, 2012, pp 1652\u20131660."},{"key":"BFgt201632_CR13","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1007\/s11095-010-0073-2","volume":"27","author":"V Filipe","year":"2010","unstructured":"Filipe V, Hawe A, Jiskoot W . Critical evaluation of nanoparticle tracking analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. Pharm Res 2010; 27: 796\u2013810.","journal-title":"Pharm Res"},{"key":"BFgt201632_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1128\/JVI.01878-08","volume":"83","author":"AL Parker","year":"2009","unstructured":"Parker AL, Waddington SN, Buckley SM, Custers J, Havenga MJ, van Rooijen N et al. Effect of neutralizing sera on factor X-mediated adenovirus serotype 5 gene transfer. J Virol 2009; 83: 479\u2013483.","journal-title":"J Virol"},{"key":"BFgt201632_CR15","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1128\/JVI.03217-14","volume":"89","author":"Q Qiu","year":"2015","unstructured":"Qiu Q, Xu Z, Tian J, Moitra R, Gunti S, Notkins AL et al. Impact of natural IgM concentration on gene therapy with adenovirus type 5 vectors. J Virol 2015; 89: 3412\u20133416.","journal-title":"J Virol"},{"key":"BFgt201632_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000136316","volume":"15","author":"G Rambach","year":"2008","unstructured":"Rambach G, Wurzner R, Speth C . Complement: an efficient sword of innate immunity. Contrib Microbiol 2008; 15: 78\u2013100.","journal-title":"Contrib Microbiol"},{"key":"BFgt201632_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1034\/j.1600-065X.2001.1800103.x","volume":"180","author":"A Sahu","year":"2001","unstructured":"Sahu A, Lambris JD . Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev 2001; 180: 35\u201348.","journal-title":"Immunol Rev"},{"key":"BFgt201632_CR18","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1038\/sj.gt.3301611","volume":"8","author":"G Cichon","year":"2001","unstructured":"Cichon G, Boeckh-Herwig S, Schmidt HH, Wehnes E, Muller T, Pring-Akerblom P et al. Complement activation by recombinant adenoviruses. Gene Ther 2001; 8: 1794\u20131800.","journal-title":"Gene Ther"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/gt201632.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/gt201632","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/gt201632.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:34:17Z","timestamp":1684416857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,25]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["BFgt201632"],"URL":"https:\/\/doi.org\/10.1038\/gt.2016.32","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,25]]},"assertion":[{"value":"21 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}